Skip to main content
. 2021 Apr 15;22(8):4102. doi: 10.3390/ijms22084102

Figure 4.

Figure 4

Ad-shRRM1 significantly inhibits cell viability of RRM1-expressing bladder cell lines. Cell viability was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after transduction with adenoviral vectors at MOI = 10 at series time point of 1, 3, 5, 7 and 9 day. (A) results in 253J cells; (B) results in RT112 cells. (MOI: multiplicity of infection; * p < 0.05, ** p < 0.005 vs. Ad-shScramble treatment).